第 1 到 9 筆結果,共 9 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome | PO-HAN LIN ; YU-WEN TIEN ; WEN-FANG CHENG ; YING-CHENG CHIANG ; Wu, Chien-Huei; Yang, Karen; CHIUN-SHENG HUANG | Journal of Gynecologic Oncology | 0 | ||
2 | 2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng, Ling-Ming; Lee, Yi-Hsuan; Chen, Shou-Tung; Yeh, Dah-Cherng; Dai, Ming-Shen; Liu, Liang-Chih; MING-YANG WANG ; Chiao Lo ; Chang, Stanley; Tan, Kien Thiam; Chen, Shu-Jen; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 6 | 4 | |
3 | 2022 | Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients | PO-HAN LIN ; Chen, Shin-Cheh; Tseng, Ling-Ming; KING-JEN CHANG ; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; WEN-HUNG KUO ; Kuo, Wen-Lin; CHING-HUNG LIN ; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; MING-YANG WANG ; Chiao Lo ; YEN-SHEN LU ; CHIUN-SHENG HUANG | Breast cancer research and treatment | 5 | 4 | |
4 | 2021 | Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy | PO-HAN LIN ; MING-YANG WANG ; Chiao Lo ; LI-WEI TSAI ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Huang, Wei-Chih; Yang, Karen; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Frontiers in Oncology | 14 | 11 | |
5 | 2020 | Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer | PO-HAN LIN ; MING CHEN; TSAI, LI-WEI ; Chiao Lo ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer science | 30 | 25 | |
6 | 2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
7 | 2016 | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer | PO-HAN LIN ; WEN-HUNG KUO ; Huang A.-C.; YEN-SHEN LU ; CHING-HUNG LIN ; SUNG-HSIN KUO ; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; SUNG-LIANG YU ; KING-JEN CHANG ; PEI-LUNG CHEN ; YEN-HSUAN NI ; CHIUN-SHENG HUANG | Oncotarget | 74 | 64 | |
8 | 2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
9 | 2010 | Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation | PO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 6 | 4 |